You are invited to attend the 2021 WSCD Virtual Conference happening July 10th! Register here - http://bit.ly/SCSSN_2021Conference
Call for Abstracts Below:
More
ASABA 2021 Virtual Conference + Call for Abstracts
Announcement
Update on SCSSN Members awarded the Brazilian FIOCRUZ Fellowships
Professor Adekunle Adekile
Between 2013 and 2018, 6 members of the Sickle Cell Support Society of Nigeria were awarded scholarships by the FIOCRUZ Foundation to pursue higher degrees in different Brazilian Universities. They all completed their programs with flying colors and in record time. They were, indeed, worthy ambassadors of the society in particular and Nigeria in general. They are all back in their home institutions, contributing to the care of sickle cell disease patients and leadi...
More
2020 World Sickle Cell Day Webinar Communique
A JOINT COMMUNIQUE RELEASED BY THE SICKLE CELL SUPPORT SOCIETY OF NIGERIA AND THE NIGERIAN SOCIETY OF HAEMATOLOGY AND BLOOD TRANSFUSION AT THE END OF THE WEBINAR TO COMMEMORATE THE 2020 WORLD SICKLE CELL DAY
We bring you greetings from the Sickle Cell Support Society Nigeria (SCSSN), who in collaboration with the Nigerian Society of Haematology and Blood Transfusion (NSHBT) has toiled to make this celebration and awareness Webinar a huge success.
Sickle cell disease (SCD) has assumed publ...
More
2020 Virtual Conference (UPDATED)
Date: Thursday June 25 2020Time: 4-7 pm Lagos / 11:00 am EST / 8:00 am PST
Theme: Reducing the Burden of Sickle Cell Disease in Nigeria- Utilizing Evidence and the Role of
Stakeholders
Chairs: Professor Adekunle Adekile and Professor Aisha Gwarzo
Coordinator: Professor Obiageli Nnodu
Guest Speaker: Dr Maureen Achebe- Brigham and Women’s Hospital, Harvard Medical School,
Boston, Massachusetts, USA.
Program
1. Chairman’s opening remarks: NSHBT & SCSSN (10 minutes)2. FMOH -...
More
Dream Maker Inc. Fellowship in SCD
The Division of Haematology/Oncology at The Hospital for Sick Children (SickKids), in partnership with Dream Legacy Foundation and the Black Innovation Fellowship Program at Ryerson University, is pleased to launch the Dream Maker Inc. Fellowship in Sickle Cell Disease in September 2020.
Directed at paediatricians in sub-Saharan Africa who have completed Paediatric Residency within the last 5 years and have demonstrated interest in patients with sickle cell disease (SCD), this will be an exc...
More
Rapid Result Test On Track to Transform Sickle Cell Disease Screening for Millions
Soon after birth, a baby in the United States is tested for sickle cell disease, the often-devastating genetic blood disorder affecting more than 100,000 Americans and 20 million of people worldwide. If positive, that newborn typically begins a course of treatment that can greatly prolong life and help stave off complications of the disease. But in sub-Saharan Africa, where the majority of sickle cell disease cases can be found—and where resources are scant—newborn screening programs are virtua...
More
Research and Training Opportunities – Sickle In Africa
Author Aid Research Writing in the Sciences
The free course is designed for researchers in developing countries, particularly those working in a scientific field (life sciences / natural sciences / other related fields). It is suitable for early career researchers, or those with limited experience in publishing papers in reputable peer-reviewed journals.
Starts 4 September Enrollment open now.
https://www.authoraid.info/en/news/details/1316/
------------------------------------...
More
Mobilizing partnerships to impact sickle cell disease in Africa
Sickle cell disease (SCD) is a neglected health problem in sub-Saharan Africa (SSA) where
more than half of affected individuals die before their 5th birthday due to preventable
complications. In response, a “Sickle-cell anemia” resolution (WHA59.20) was passed at the
59th World Health Assembly in 2006, urging Member States and the WHO Director-General
to promote and support actions to address SCD. That was followed in 2010 with adoption by
the WHO Regional Office for Africa of “Sickle-cell...
More
Uche Ndidi Defends His PhD
A recipient of the FIOCRUZ scholarship - Uche Ndidi defends his PhD thesis on "Effect of Carboxymethyl lysine, anadvanced glycation end product, on sickle cell disease” at the INSTITUTO GONÇALO MONIZ-FUNDAÇÁO OSWALDO CRUZ (IGM-FIOCRUZ), Bahia, Brazil in the Curso de Pós-Graduação em Biotecnologia em Saúde e Medicina Investigativa (PgBSMI) (Postgraduate course in Biotechnology in health and Investigative Medicine) on June 19, 2018.
More